13F Data
13F filer · CIK 1595725

Rock Springs Capital Management LP

Baltimore, MD · filing since Q4 2013 · last filing Aug 14, 2026
Reported value
$2.0B
+$352.2M vs prior
Positions
104
New / sold out
17 / 13
Added / reduced
40 / 30
Turnover
13.7%
buys $256.1M · sells $263.1M
Top-10 weight
44.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewASCENDIS PHARMA A/S+168,750–+$45.0M
AddedTRAVERE THERAPEUTICS INC+701,115+47.4%+$39.8M
NewAVALYN PHARMACEUTICALS INC+662,918–+$21.8M
NewHEMAB THERAPEUTICS HLDGS INC+575,432–+$21.1M
NewPARABILIS MEDICINES INC+578,028–+$15.8M
AddedCYTOKINETICS INC+142,616+314.4%+$12.1M
AddedMINIMED GROUP INC+465,000+44.1%+$7.0M
NewOMEROS CORP+718,499–+$6.8M
NewDEFINIUM THERAPEUTICS INC+143,187–+$6.7M
NewMOBIA MED INC+418,200–+$5.6M
47 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outASCENDIS PHARMA A/S-194,000-100.0%$-44.4M
ReducedARGENX SE-45,750-46.4%$-42.4M
ReducedREVOLUTION MEDICINES INC-104,255-8.6%$-19.5M
Sold outARCELLX INC-169,859-100.0%$-19.5M
ReducedENLIVEN THERAPEUTICS INC-361,875-43.8%$-18.4M
Sold outCENTESSA PHARMACEUTICALS PLC-351,828-100.0%$-14.0M
ReducedAGIOS PHARMACEUTICALS INC-266,600-33.4%$-9.9M
Sold outSOLENO THERAPEUTICS INC-257,253-100.0%$-8.6M
ReducedULTRAGENYX PHARMACEUTICAL IN-250,918-20.6%$-8.4M
Sold outREGENERON PHARMACEUTICALS-10,100-100.0%$-7.8M
33 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2013: $279.9MQ1 2014: $433.6MQ2 2014: $557.7MQ3 2014: $646.4MQ4 2014: $854.9MQ1 2015: $1.1BQ2 2015: $1.4BQ3 2015: $1.2BQ4 2015: $1.3BQ1 2016: $1.2BQ2 2016: $1.4BQ3 2016: $1.6BQ4 2016: $1.5BQ1 2017: $1.7BQ2 2017: $2.0BQ3 2017: $2.2BQ4 2017: $2.2BQ1 2018: $2.3BQ2 2018: $2.6BQ3 2018: $2.8BQ4 2018: $2.1BQ1 2019: $2.6BQ2 2019: $2.8BQ3 2019: $2.5BQ4 2019: $3.2BQ1 2020: $2.4BQ2 2020: $3.6BQ3 2020: $3.9BQ4 2020: $4.7BQ1 2021: $4.6BQ2 2021: $5.1BQ3 2021: $4.8BQ4 2021: $4.3BQ1 2022: $4.0BQ2 2022: $3.4BQ3 2022: $3.9BQ4 2022: $4.2BQ1 2023: $4.2BQ2 2023: $4.2BQ3 2023: $3.7BQ4 2023: $4.1BQ1 2024: $3.9BQ2 2024: $3.3BQ3 2024: $3.1BQ4 2024: $2.6BQ1 2025: $1.7BQ2 2025: $1.6BQ3 2025: $1.7BQ4 2025: $2.0BQ1 2026: $1.7BQ2 2026: $2.0B
Q4 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1REVOLUTION MEDICINES INCCOM1,105,210$207.0M10.10%
2TRAVERE THERAPEUTICS INCCOM2,179,069$123.8M6.04%
3LLYELI LILLY & CO98,700$118.4M5.78%
4MADRIGAL PHARMACEUTICALS INCCOM174,999$94.0M4.59%
5MIRUM PHARMACEUTICALS INCCOM798,145$93.4M4.56%
6RHYTHM PHARMACEUTICALS INCCOM692,598$76.9M3.75%
7KYMERA THERAPEUTICS INCCOM453,156$52.0M2.54%
8ARGENX SESPONSORED ADR52,750$48.9M2.39%
9ASCENDIS PHARMA A/SORD SHS168,750$45.0M2.20%
10XENON PHARMACEUTICALS INCCOM683,907$41.3M2.01%
94 more rows. Subscribe for $29/month to see every row, download the data and use the API.